构建基于人类多能干细胞的性腺微环境:以体内见解改进体外系统
本叙述性综述检索PubMed至2025年2月,将人类及小鼠性腺体内分化知识与人类多能干细胞体外分化为睾丸或卵巢体细胞微环境的方案相连接,聚焦细胞间信号因子。现有方案包括序贯生长因子分化、省略中间阶段的定向分化及关键转录因子过表达,但生成细胞的分子与功能验证有限,完全体外配子发生尚未实现。
要点
- 综述连接体内性腺分化知识与体外多能干细胞分化方案,聚焦细胞间信号因子。
- 现有方案包括序贯生长因子分化、省略中间体的定向分化及关键转录因子过表达。
- 生成细胞类型的分子与功能验证有限,完全人类体外配子发生尚未实现。
核心结论
- 将体内性腺发育知识与改进的分化方案整合,有望在体外可靠生成性腺体细胞微环境,从而更准确模拟性腺并深入理解正常与病理过程,包括不孕或性发育差异相关机制。
研究设计与样本
- 叙述性综述,检索PubMed数据库至2025年2月,主题包括人类与小鼠体内性腺分化、人类胚胎干细胞或人类诱导多能干细胞体外分化为性腺体细胞(双潜能、Sertoli或颗粒细胞)及方案所用细胞间信号因子的证据。
主要发现
- 综述了旨在将人类多能干细胞分化为性腺体细胞谱系的多种策略,包括重现全部已知发育祖细胞阶段的序贯生长因子分化、省略一个或多个发育中间体的定向生长因子分化以及关键转录因子的定向过表达。
- 基于生长因子的方案使用多种细胞间信号因子诱导分化,部分源自体内研究,部分缺乏直接体内证据。
- 尽管在引导多能干细胞向性腺分化方面取得显著进展,仍存在挑战,如生成细胞类型的分子与功能验证有限。
- 通过多能细胞来源生殖细胞共培养技术实现完全人类体外配子发生尚未达成,表明当前方案尚未获得性腺微环境的完全功能成熟。
局限性
- 生成细胞类型的分子与功能验证有限。
- 完全人类体外配子发生尚未实现,表明当前方案尚未获得性腺微环境的完全功能成熟。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The gonadal somatic niche is crucial for sex determination and gamete formation throughout the human life cycle. However, key steps in gonadal somatic lineage differentiation occur during embryonic and foetal development, making them difficult to study in humans. In vitro differentiation models are therefore needed to investigate gonadal development, support in vitro gametogenesis, and study infertility. A comprehensive overview of gonadal somatic niche differentiation, both in vivo and in vitro, is thus crucial. OBJECTIVE AND RATIONALE: This review connects in vivo knowledge with in vitro differentiation systems for gonadal somatic niches, predominantly focusing on cell-cell signalling factors. It evaluates existing in vitro protocols for differentiating testicular and ovarian somatic niches, discusses them in the context of in vivo findings, and explores potential advancements in model systems. SEARCH METHODS: A narrative review was conducted after a comprehensive search of the PubMed database through to February 2025; the review focused on search topics including: in vivo gonadal differentiation in humans and mice; in vitro differentiation of human embryonic stem cells or human-induced pluripotent stem cells into gonadal somatic cells (bipotential, Sertoli or granulosa cells); and evidence for the cell-cell signalling factors used in these protocols. OUTCOMES: We investigated various strategies that aim to differentiate human pluripotent stem cells into gonadal somatic cell lineages. These include sequential growth factor differentiation recapitulating all known developmental progenitor stages, directed growth factor differentiation that omitted one or more developmental intermediates, and directed overexpression of key transcription factors. To induce differentiation, the growth factor-based protocols used various cell-cell signalling factors, with some derived from in vivo studies, while others lacked direct in vivo evidence. Despite significant advances in guiding pluripotent stem cells towards gonadal differentiation, challenges remain, such as the limited molecular and functional validation of the generated cell types. Consequently, complete human in vitro gametogenesis through co-culture techniques with pluripotent cell-derived germ cells has not yet been achieved, indicating that full functional maturation of the gonadal niche has not been attained with the current protocols. WIDER IMPLICATIONS: Integrating knowledge on in vivo gonadal development with enhanced differentiation protocols offers the potential to reliably generate the gonadal somatic niche in vitro. This allows for more accurate modelling of the gonad, facilitating deeper insights into the normal and pathological processes involved in gonadal development and germ cell maturation. For example, it could help to identify mechanisms linked to infertility or differences of sex development. Importantly, as many of these models are based on human pluripotent stem cells, they have the potential for personalization, enabling future patient-specific models for studying reproductive disorders and developing tailored fertility treatments. REGISTRATION NUMBER: n/a.
引用
- Lakshmipathi M, Dartée N, Puchkina A, et al. Building a human pluripotent stem cell-based gonadal niche: improving in vitro systems with in vivo insights. Hum Reprod Update. 2025. PMID: 40580487. doi:10.1093/humupd/dmaf012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。